Enforcement Report - Week of November 29, 2023
Enforcement Report - Week of March 8, 2023
Cingulate has posted pharmacokinetic data from an early-phase clinical trial of its triple-release anxiety drug candidate, providing itself with a platform to support development of a planned once-daily therapy.
Enforcement Report- Week of June 9, 2021
Enforcement Report - Week of September 2, 2020
Unichem lab's Generic Buspirone hydrochloride Receives Approval in US
Drug firm Unichem Laboratories on Friday said it has received approval from the US health regulator to market its generic Buspirone Hydrochloride tablets used for management of anxiety disorders.
Epic Pharma Generic Buspirone Hydrochloride Receives Approval in US
Amneal Pharm’s Generic Buspirone Hydrochloride Receives Approval In Us
Emcure Pharms` Generic Buspirone Hydrochloride (5, 15mg) approved in US for Anxiety